Dr LIU is an expert in immunology and has studied in Birmingham where he also received his postdoctoral training. In 1991, he joined DNAX Schering Ploug Research Center and moved in 2002 to the Texas MD Anderson Cancer Center. He later became VP and Chief Scientist of Baylor Research Institute and Senior VP of MedImmune Inc. The Chinese media celebrate the career of this scientist to become head of R&D of a global Western drug company.

China Bio news release, April 6, 2016